中文 | English
Return
Total: 3 , 1/1
Show Home Prev Next End page: GO
Author:(Huijin LUO)

1.Triple combination therapy using saxagliptin/metformin/rosiglitazone versus intensive insulin therapy in the treatment of newly-diagnosed type 2 diabetes:Effects on glycaemic control andα/β-cell function

Huijin LUO ; Rongping CHEN ; Rui YANG ; Zhen ZHANG ; Min YI ; Hong CHEN

Chinese Journal of Endocrinology and Metabolism 2015;(6):515-517

2.Protection of Saxagliptin for liver inflammatory injury in rat model of diabetes complicating with nonalcoholic fatty liver disease and its mechanism

Huijin LUO ; Yan LIU ; Rongping CHEN ; Shuangshuang ZHANG ; Hong CHEN ; Zhen ZHANG

Chinese Journal of Endocrinology and Metabolism 2015;(6):538-540

3.Discovery of a subtype-selective, covalent inhibitor against palmitoylation pocket of TEAD3.

Tian LU ; Yong LI ; Wenchao LU ; Twgm SPITTERS ; Xueyu FANG ; Jun WANG ; Simian CAI ; Jing GAO ; Yanting ZHOU ; Zhe DUAN ; Huan XIONG ; Liping LIU ; Qi LI ; Hualiang JIANG ; Kaixian CHEN ; Hu ZHOU ; Hua LIN ; Huijin FENG ; Bing ZHOU ; Christopher L ANTOS ; Cheng LUO

Acta Pharmaceutica Sinica B 2021;11(10):3206-3219

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 3 , 1/1 Show Home Prev Next End page: GO